β-catenin involvement in arsenite-induced VEGF expression in neuroblastoma SH-SY5Y cells

Environmental Toxicology

Volumn 29, Issue 6, 2014, Pages 672-678

  Watcharasit, Piyajit ^a,b,c   Suntararuks, Sumitra ^a   Visitnonthachai, Daranee ^a   Thiantanawat, Apinya ^a,b,c   Satayavivad, Jutamaad ^a,b,c  

^a Chulabhorn Research Institute   (Thailand)

^b Research and Innovation   (Thailand)

^c Center of Excellence on Environmental Health and Toxicology (EHT) Office of the Higher Education Commission   (Thailand)

Author keywords

Arsenite; GSK3; HIF 1 ; VEGF; catenin

Indexed keywords

ARSENIC; CELL ENGINEERING; CHEMICAL ACTIVATION; CYTOLOGY; ENZYMES; PATHOLOGY;

ARSENITE; GSK3; NEUROBLASTOMAS; NUCLEAR ACCUMULATION; SH-SY5Y CELLS; TRANSCRIPTIONAL ACTIVATORS; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF;

ENDOTHELIAL CELLS;

ARSENITE; GSK3; HIF-1Α; VEGF; Β-CATENIN;

ARSENITES; BETA CATENIN; CELL LINE, TUMOR; CELL NUCLEUS; CHROMONES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MORPHOLINES; NEUROBLASTOMA; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84898916911     PISSN: 15204081     EISSN: 15227278     Source Type: Journal    
DOI: 10.1002/tox.21794     Document Type: Article

References (31)

1. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789.
2. Duyndam MC, Hulscher ST, van der Wall E, Pinedo HM, Boven E. 2003. Evidence for a role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite. J Biol Chem 278:6885-6895.
3. Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garrett E, Wiesmann M, Garcia PD, Fuller JH, Chan V, Randazzo F, Gundel R, Warren RS, Escobedo J, Aukerman SL, Taylor RN, Fantl WJ. 2003. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res 63:3145-3153.
4. Fang X, Yu S, Tanyi JL, Lu Y, Woodgett JR, Mills GB. 2002. Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway. Mol Cell Biol 22:2099-2110.
5. Fang X, Yu SX, Lu Y, Bast RCJr, Woodgett JR, Mills GB. 2000. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci USA 97:11960-11965.
6. Ferrara N. 2009. VEGF-A: A critical regulator of blood vessel growth. Eur Cytokine Netw 20:158-163.
7. Florea AM, Splettstoesser F, Busselberg D. 2007. Arsenic trioxide (As2O3) induced calcium signals and cytotoxicity in two human cell lines: SY-5Y neuroblastoma and 293 embryonic kidney (HEK). Toxicol Appl Pharmacol 220:292-301.
8. Gao N, Shen L, Zhang Z, Leonard SS, He H, Zhang XG, Shi X, Jiang BH. 2004. Arsenite induces HIF-1alpha and VEGF through PI3K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells. Mol Cell Biochem 255:33-45.
9. Goytia-Acevedo RC, Cebrian ME, Calderon-Aranda ES. 2003. Differential effects of arsenic on intracellular free calcium levels and the proliferative response of murine mitogen-stimulated lymphocytes. Toxicology 189:235-244.
10. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
11. Kamat CD, Green DE, Curilla S, Warnke L, Hamilton JW, Sturup S, Clark C, Ihnat MA. 2005. Role of HIF signaling on tumorigenesis in response to chronic low-dose arsenic administration. Toxicol Sci 86:248-257.
12. Kao YH, Yu CL, Chang LW, Yu HS. 2003. Low concentrations of arsenic induce vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vitro. Chem Res Toxicol 16:460-468.
13. Kimelman D, Xu W. 2006. beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene 25:7482-7491.
14. Liu LZ, Jiang Y, Carpenter RL, Jing Y, Peiper SC, Jiang BH. 2011. Role and mechanism of arsenic in regulating angiogenesis. PLoS One 6:e20858.
15. MacDonald BT, Tamai K, He X. 2009. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17:9-26.
16. Patterson TJ, Rice RH. 2007. Arsenite and insulin exhibit opposing effects on epidermal growth factor receptor and keratinocyte proliferative potential. Toxicol Appl Pharmacol 221:119-128.
17. Polakis P. 2007. The many ways of Wnt in cancer. Curr Opin Genet Dev 17:45-51.
18. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Ze'ev A. 1999. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96:5522-5527.
19. Silva R, Martins L, Longatto-Filho A, Almeida OF, Sousa N. 2007. Lithium prevents stress-induced reduction of vascular endothelium growth factor levels. Neurosci Lett 429:33-38.
20. Skurk C, Maatz H, Rocnik E, Bialik A, Force T, Walsh K. 2005. Glycogen-Synthase Kinase3beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells. Circ Res 96:308-318.
21. Song B, Lai B, Zheng Z, Zhang Y, Luo J, Wang C, Chen Y, Woodgett JR, Li M. 2010. Inhibitory phosphorylation of GSK-3 by CaMKII couples depolarization to neuronal survival. J Biol Chem 285:41122-41134.
22. Soucy NV, Ihnat MA, Kamat CD, Hess L, Post MJ, Klei LR, Clark C, Barchowsky A. 2003. Arsenic stimulates angiogenesis and tumorigenesis in vivo. Toxicol Sci 76:271-279.
23. Soucy NV, Klei LR, Mayka DD, Barchowsky A. 2004. Signaling pathways for arsenic-stimulated vascular endothelial growth factor-a expression in primary vascular smooth muscle cells. Chem Res Toxicol 17:555-563.
24. Soucy NV, Mayka D, Klei LR, Nemec AA, Bauer JA, Barchowsky A. 2005. Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice. Cardiovasc Toxicol 5:29-41.
25. States JC, Srivastava S, Chen Y, Barchowsky A. 2009. Arsenic and cardiovascular disease. Toxicol Sci 107:312-323.
26. Suriyo T, Watcharasit P, Thiantanawat A, Satayavivad J. 2012. Arsenite promotes apoptosis and dysfunction in microvascular endothelial cells via an alteration of intracellular calcium homeostasis. Toxicol In Vitro 26:386-395.
27. Takahashi H, Shibuya M. 2005. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond) 109:227-241.
28. Tchounwou PB, Patlolla AK, Centeno JA. 2003. Carcinogenic and systemic health effects associated with arsenic exposure--A critical review. Toxicol Pathol 31:575-588.
29. Thirunavukkarasu M, Han Z, Zhan L, Penumathsa SV, Menon VP, Maulik N. 2008. Adeno-sh-beta-catenin abolishes ischemic preconditioning-mediated cardioprotection by downregulation of its target genes VEGF, Bcl-2, and survivin in ischemic rat myocardium. Antioxid Redox Signal 10:1475-1484.
30. Tseng CH, Tseng CP, Chiou HY, Hsueh YM, Chong CK, Chen CJ. 2002. Epidemiologic evidence of diabetogenic effect of arsenic. Toxicol Lett 133:69-76.
31. Watcharasit P, Visitnonthachai D, Suntararuks S, Thiantanawat A, Satayavivad J. 2012. Low arsenite concentrations induce cell proliferation via activation of VEGF signaling in human neuroblastoma SH-SY5Y cells. Environ Toxicol Pharmacol 33:53-59.